Skip to main content
. 2013 Jan 8;185(1):E70–E77. doi: 10.1503/cmaj.112161

Table 3:

Death or major cardiovascular event after Escherichia coli O157:H7 gastroenteritis among participants in the Walkerton Health Study with no gastroenteritis (n = 331), mild gastroenteritis (n = 414) or severe gastroenteritis (n = 153)

Group No. (%) No. events per 1000 person-years Hazard ratio (95% confidence interval)
Unadjusted Adjusted*
Death or major cardiovascular event
No gastroenteritis 28 (8.5) 11.4 1.0 (ref) 1.0 (ref)
Mild gastroenteritis 22 (5.3) 6.9 0.61 (0.35–1.10) 0.63 (0.36–1.10)
Severe 9 (5.9) 7.9 0.70 (0.33–1.46) 0.75 (0.35–1.59)
Mild or severe gastroenteritis (2 groups combined), n = 567 31 (5.5) 7.2 0.63 (0.38–1.05) 0.66 (0.39–1.10)
Major cardiovascular event (death censored)
No gastroenteritis 8 (2.4) 3.3 1.0 (ref) 1.0 (ref)
Mild gastroenteritis 13 (3.1) 4.1 1.30 (0.52–3.03) 1.21 (0.50–2.97)
Severe gastroenteritis 6 (3.9) 5.3 1.16 (0.57–4.60) 1.76 (0.61–5.10)
Mild or severe gastroenteritis, n = 567 19 (3.4) 4.4 1.35 (0.59–3.08) 1.35 (0.59–3.12)
Death (all causes)
None gastroenteritis 20 (6.0) 8.0 1.0 (ref) 1.0 (ref)
Mild gastroenteritis 10 (2.4) 3.1 0.39 (0.18–0.83) 0.41 (0.19–0.89)
Severe gastroenteritis 0.33 (0.10–1.13)
Mild or severe gastroenteritis, n = 567 0.39 (0.19–0.79)
*

Adjusted for age, sex, income quintile, diabetes, hypertension, and low sodium diet.

Not reported because of count data less than 6. With such low counts, there is a risk of reidentification using Institute for Clinical Evaluative Sciences data. This is under the agreement between the Institute for Clinical Evaluative Sciences and the privacy officer of Ontario.